Wu et al. MDA5-DM. Propensity-score cohort study. 672 patients. Tofacitinib vs CNI. Primary outcome 1 year death or lung transplant. HR 0.70 favouring tofacitinib. @RheumNow #ACR24 Abstr#1736 https://t.co/A0aHhp1q9c https://t.co/LbutJDBllr
Links:
Effectiveness and Safety of Tofacitinib vs. Calcineurin Inhibitor in Interstiti…
https://acrabstracts.org/abstract/effectiveness-and-safety-of-tofacitinib-vs-ca…
17-11-2024